A board-certified physician, Jeff has nearly 20 years of experience in the pharmaceutical industry. Before joining IDM Pharma, Jeff was Vice President of Clinical Science at Takeda Global Research and Development. He has also served as the Chief Medical Officer and Executive Vice President at NeoPharm, Inc. Jeff has also held various positions at Searle/Pharmacia Research and Development, including Director, Senior Director, and Executive Director of Clinical Research, where he managed clinical development activities for a variety of therapeutic areas, including infectious diseases, women’s health, sleep, and the central nervous system. Jeff went on to lead company-wide oncology clinical research as Executive Director, Clinical Research and then oncology medical marketing as Head, Oncology Global Medical Operations. Prior to joining Searle/Pharmacia, Jeff worked at Bristol-Myers Squibb in Clinical Pharmacology and Clinical Research.

Jeff received his medical degree from the Rosalind Franklin University/Chicago Medical School. He completed an internship and residency in internal medicine at Northwestern University, where he also served as chief medical resident. Additionally, he completed a fellowship in infectious diseases with an interest in immunocompromised patients at the University of California-San Francisco (UCSF) and was a research associate in allergy and immunology at the Howard Hughes Medical Institute at UCSF. Jeff is an Adjunct Assistant Professor of Medicine at the Northwestern University Feinberg School of Medicine and a member of several professional societies as well as a Diplomat of the National Board of Medical Examiners and the American Board of Internal Medicine. 

Jeff is a member of the DIA Board of Directors and received a DIA Outstanding Service Award in 2001.